Im therapeutics expands management team with appointments of tom shea as cfo/coo and dr. sarah bird as vp, clinical development

Immunomolecular therapeutics, inc. (“im therapeutics”), a leading innovator in the field of precision medicine for autoimmune disease, announced today

ALBO Ratings Summary

ALBO Quant Ranking